3.37

2.03% -0.07

After Hours: 3.37

Embecta Corp (EMBC)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Embecta Corp stock is traded at $3.37, with a volume of 1.54M. It is down -2.03% in the last 24 hours and up +8.36% over the past month. Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Previous Close:

$3.44

Open:

$3.4

24h Volume:

1.54M

Relative Volume:

0.64

Market Cap:

$199.93M

Revenue:

$1.04B

Net Income/Loss:

$111.90M

P/E Ratio:

1.7106

EPS:

1.9701

Net Cash Flow:

$205.80M

1W Performance:

+8.71%

1M Performance:

+8.36%

6M Performance:

-72.67%

1Y Performance:

-67.25%

1-Day Range:

$3.325

$3.4696

1-Week Range:

$3.10

$3.4696

52-Week Range:

$2.77

$15.55

Embecta Corp Stock (EMBC) Company Profile

Name

Embecta Corp

Sector

Healthcare (1080)

Industry

Medical Instruments & Supplies (57)

Phone

(862) 401-0000

Address

300 KIMBALL DRIVE, PARSIPPANY

Employee

1,850

Twitter

Next Earnings Date

2026-08-14

Latest SEC Filings

EMBC's Discussions on Twitter

Compare EMBC vs ISRG, BDX, MDLN, ALC, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EMBC Embecta Corp	3.37	204.09M	1.04B	111.90M	205.80M	1.9701
ISRG Intuitive Surgical Inc	350.06	125.08B	11.03B	3.16B	2.83B	8.7254
BDX Becton Dickinson Co	153.84	42.57B	21.37B	1.41B	3.07B	3.9437
MDLN Medline Inc	39.09	32.88B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	67.35	34.16B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	195.80	28.81B	5.54B	1.52B	1.74B	10.37

Embecta Corp Stock (EMBC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-10-25	Initiated	Mizuho	Neutral
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight
Jun-21-22	Initiated	BofA Securities	Underperform

View All

Embecta Corp Stock (EMBC) Latest News

01:31 AM

Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost - GlobeNewswire

01:31 AM

12:00 PM

Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire

12:00 PM

10:27 AM

EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with the Schall ... - Hastings Tribune

10:27 AM

10:25 AM

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 17, 2026 in Embecta Corp. LawsuitEMBC - Morningstar

10:25 AM

08:30 AM

Kaplan Fox Encourages Investors of Embecta Corp. (EMBC) Who Suffered Losses to Contact the Firm Before August 17, 2026 - TMX Newsfile

08:30 AM

06:17 AM

Lawsuit Notice: $EMBC Legal News: Embecta Insulin Pen Issues and 57% Stock Drop Trigger Securities Fraud Class Action - TradingView

06:17 AM

Jul 20, 2026

EMBC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Embecta Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 - marketscreener.com

Jul 20, 2026